$Pfizer (PFE.US)$ Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023. The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease. Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia. Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times
BadPaint
BadPaint
:
Thanks for the GSAT play Ryan! This looks gnarly with a lot of potential with the partnership of Apple funding a constelltion of satellite expansion.
Ryand83
OP
BadPaint
:
my only concern is even after the uplist reverse split the share count will still be 100m or so. Wonder if it will pump pre-split
$Pfizer (PFE.US)$ Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs. Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors. Most of the price hikes are below 10% and are to list prices, which do not i...
Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease.
Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia.
Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times
As we enter 2025 and put aside the Santa Rally’s absence, investors could be looking at another indicator which has correctly forecasted full year stock performance with a 70 to 80% accuracy since 1950.
Check out the video to find out more.
Stocks covered in the video (technical analysis) – SPY, Apple, Tesla, Google, Meta, Microsoft, Nvidia + Option trades
$Netflix (NFLX.US)$ $Advanced Micro Devices (AMD.US)$ $Taiwan Semiconductor (TSM.US)$ $Salesforce (CRM.US)$ $CrowdStrike (CRWD.US)$ $Adobe (ADBE.US)$ $Enphase Energy (ENPH.US)$ $KraneShares CSI China Internet ETF (KWEB.US)$ $Arm Holdings (ARM.US)$ $MARA Holdings (MARA.US)$ $Riot Platforms (RIOT.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Johnson & Johnson (JNJ.US)$ $JPMorgan (JPM.US)$ $Disney (DIS.US)$
New Positions
$Uber Technologies (UBER.US)$ , $Global X Funds Mlp & Energy Infrastructure Etf (MLPX.US)$ , $Life360 (LIF.US)$
Increased Positions
$Energy Select Sector SPDR Fund (XLE.US)$ , $Occidental Petroleum (OXY.US)$ , $Johnson & Johnson (JNJ.US)$ , $Advanced Micro Devices (AMD.US)$
Decreased Positions
$Tesla (TSLA.US)$
Sold out Positions
$Hut 8 (HUT.US)$ (Lost 13.3%) , $Innodata (INOD.US)$ (Profit 5...
loading...
reddit.com/r/GS...
Can't be sitting around waiting on $ROCHE HOLDING AG (RHHBY.US)$ to finalize this deal 🍻
Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs.
Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors.
Most of the price hikes are below 10% and are to list prices, which do not i...
No comment yet